Janssen Research and Development
University of Arizona
United States of America
Robin L.Thurmond, Ph.D. is the Early Development Portfolio Leader for Rheumatology and Psoriasis with the Clinical Research group at Janssen Research & Development in La Jolla, CA. Prior to that Dr.Thurmond was a Research Fellow with the Immunology Drug Discovery group at the same site. Dr. Thurmond's research involves investigation of novel mechanisms of action targeting new anti-inflammatory medicines for diseases such as asthma, atopic dermatitis and rheumatoid arthritis. Dr. Thurmond is a recognized expert in histamine receptors and their role in inflammation with over 90 scientific articles, reviews and book chapters as well as the editor of a book on histamine in inflammation.He received his B.A. in Chemistry from the University of Virginia and his Ph.D. in Biochemistry from the University of Arizona. Dr. Thurmond studied membrane biophysics at the University of Arizona and worked on the molecular aspects of rhodopsin function during his postdoctoral training at the Massachusetts Institute of Technology with Dr. Gobind Khorana, Nobel Laurate 1968. He began his career with Johnson & Johnson in 1996 at the R.W. Johnson Pharmaceutical Research Institute in Raritan N.J. and has been with Johnson & Johnson for 20 years.